Cited by 746SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

Open access
To, Kelvin Kai-Wang, Hung, Ivan Fan-Ngai, Ip, Jonathan Daniel, Chu, Allen Wing-Ho, Chan, Wan-Mui, Tam, Anthony Raymond, Fong, Carol Ho-Yan, Yuan, Shuofeng +12 more·2021·Clinical Infectious Diseases

Abstract

Background: Waning immunity occurs in patients who have recovered from Coronavirus Disease 2019 (COVID-19). However, it remains unclear whether true re-infection occurs. Methods: Whole genome sequencing was performed directly on respiratory specimens collected during 2 episodes of COVID-19 in a patient. Comparative genome analysis was conducted to differentiate re-infection from persistent viral shedding. Laboratory results, including RT-PCR Ct values and serum Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgG, were analyzed. Results: The second episode of asymptomatic infection occurred 142 days after the first symptomatic episode in an apparently immunocompetent patient. During the second episode, there was evidence of acute infection including elevated C-reactive protein and SARS-CoV-2 IgG seroconversion. Viral genomes from first and second episodes belong to different clades/lineages. The virus genome from the first episode contained a a stop codon at position 64 of ORF8, leading to a truncation of 58 amino acids. Another 23 nucleotide and 13 amino acid differences located in 9 different proteins, including positions of B and T cell epitopes, were found between viruses from the first and second episodes. Compared to viral genomes in GISAID, the first virus genome was phylogenetically closely related to strains collected in March/April 2020, while the second virus genome was closely related to strains collected in July/August 2020. Conclusions: Epidemiological, clinical, serological, and genomic analyses confirmed that the patient had re-infection instead of persistent viral shedding from first infection. Our results suggest SARS-CoV-2 may continue to circulate among humans despite herd immunity due to natural infection. Further studies of patients with re-infection will shed light on protective immunological correlates for guiding vaccine design.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciaa1275

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. To KK, Chan WM, Ip JD, et al. Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong. Clin Infect Dis 2021; 73:137-42.
  2. Camacho C, Coulouris G, Avagyan V, et al. BLAST+: architecture and applica- tions. BMC Bioinformatics 2009; 10:421.
  3. Hu J, He CH, Gao QZ, et al. The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity and decreases neutralization sensitivity to individual convalescent sera. bioRxiv 2020; doi:10.1101/2020.06.20.161323. · DOI

Cited by

Sorted by citations

Authors
To, K. K.-W., Hung, I. F.-N., Ip, J. D., Chu, A. W.-H., Chan, W.-M., Tam, A. R., Fong, C. H.-Y., Yuan, S., Tsoi, H.-W., Ng, A. C.-K., Lee, L. L.-Y., Wan, P., Tso, E. Y.-K., To, W.-K., Tsang, D. N.-C., Chan, K.-H., Huang, J.-D., Kok, K.-H., Cheng, V. C.-C., & Yuen, K.-Y.
Affiliations
  • Queen Mary Hospital (CN)
  • University of Hong Kong (HK)
  • Department of Accident and Emergency Medicine, Tin Shui Wai Hospital, Hong Kong Special Administrative Region, China
  • Department of Accident and Emergency, North Lantau Hospital, Hong Kong Special Administrative Region, China
  • United Christian Hospital (CN)
  • Princess Margaret Hospital (HK)
  • Department of Health (CN)
Corresponding author
Yuen, Kwok-Yung
Venue
Clinical Infectious Diseases
Published
2020-08-25
Volume
73
Issue
9
Pages
e2946-e2951
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W3080458234
Cited by
746
References
35
Citations by year
2026: 1 · 2025: 6 · 2024: 35 · 2023: 50 · 2022: 133 · 2021: 364 · 2020: 156 · 2014: 1
FWCI
23.13
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Consultancy Service
  • HKSAR
  • Theme-Based Research Scheme (T11/707/15)
  • Research Grants Council
  • Shaw Foundation Hong Kong
  • Respiratory Viral Research Foundation Limited
  • Charity Fund Limited
  • Memorial Charitable Foundation
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
Keywords
COVID-19 pandemic, SARS-CoV-2 reinfection, waning immunity, prolonged viral shedding, viral epitopes, herd immunity, vaccine design
MeSH terms
Whole Genome Sequencing, Reinfection, COVID-19, SARS-CoV-2, Antibodies, Viral, Humans, Genome, Viral

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review